Loading interface...

Zytrav Eye Drops

Manufactured byZydus Cadila
ContainsTravoprost
Description

Zytrav Eye Drops is a prostaglandin F2-alpha analog that is used for the treatment of increased fluid pressure inside the eye (intraocular hypertension) and open-angle glaucoma, a progressive condition that may eventually lead to vision loss. This medicine is not recommended for use in patients below 16 years of age.

Side effects

Major & minor side effects for Zytrav Eye Drops

  • Blurred vision
  • Eye pain
  • Dry eyes
  • Redness of the eye
  • Burning or itching of eyes
  • Eye discharge
  • Headache

Uses of Zytrav Eye Drops

What is it prescribed for?

  • Intraocular hypertension
  • Open angle Glaucoma
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 2 to 4 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may prescribe a safer alternative based on your clinical condition. If the medicine is used, monitor the infant closely for any adverse effects.

Allergy

This medicine is not recommended for use in patients with a known allergy to travoprost or any other inactive ingredients present along with this medicine.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may prescribe a safer alternative based on your clinical condition. If the medicine is used, monitor the infant closely for any adverse effects.
General warnings

Contact lens

This medicine is not recommended for use if you are wearing soft contact lenses in your eyes. The lens should be removed prior to administration of the eye drops and can be reinserted 15 minutes post administration.

Eyelash changes and Pigmentation

Use of this medicine may cause some changes in eyelashes such as an increased length, thickness, pigmentation, the number of lashes or hairs, and misdirected growth of eyelashes. This medicine may also change the eye color by increasing the amount of brown pigment in the iris.

Aphakic patients

This medicine should be used with caution in patients suffering from aphakia (absence of lens) due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Use in pediatrics

This medicine is not recommended for use in patients below 16 years of age since the safety and efficacy of use are not clinically established.

Intraocular inflammation

This medicine should be used with caution in patients with an active intraocular inflammation due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Bacterial keratitis

If the ophthalmic solution of this medicine is contaminated by bacteria, it can lead to an infection of the cornea (bacterial keratitis). Patients are advised to take all hygienic precautions to ensure that the medicine is not contaminated.

Driving or operating machines

This medicine may cause blurred vision in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience this symptom during treatment with this medicine.

Missed Dose

If a dose of this medicine is missed, skip the missed dose and administer the next dose at the regularly scheduled time. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Bimatoprost

Tafluprost

Disease interactions

Macular edema

This medicine should be used with caution in patients with macular edema due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative may be required based on the clinical condition of the patient.

Uveitis

This medicine should be used with caution in patients with uveitis or active intraocular inflammation due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative may be required based on the clinical condition of the patient.

Renal Diseases

This medicine should be used with caution in patients with renal diseases due to the increased risk of adverse effects. Close monitoring of renal function, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Liver Disease

This medicine should be used with caution in patients with liver diseases due to the increased risk of adverse effects. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
Use this medicine exactly as prescribed. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by reducing the fluid pressure inside the eyes.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Ophthalmic glaucoma agents

Schedule

Schedule H

DailyMed - Travoprost solution [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 27 March 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=61987047-f322-4477-8a82-4d61fbd8bb37

Travoprost Ophthalmic: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 27 March 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a602027.html

Travoprost - DrugBank [Internet]. Drugbank.ca. 2018 [cited 27 March 2018]. Available from:

https://www.drugbank.ca/drugs/DB00287

Bondulc 40micrograms/ml Eye Drops, Solution - Summary of Product Characteristics (SmPC) - (eMC) [Internet]. Medicines.org.uk. 2018 [cited 27 March 2018]. Available from:

https://www.medicines.org.uk/emc/product/2667

[Internet]. Accessdata.fda.gov. 2018 [cited 27 March 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021994lbl.pdf

[Internet]. Pdf.hres.ca. 2018 [cited 27 March 2018]. Available from:

https://pdf.hres.ca/dpd_pm/00008165.PDF

[Internet]. Pharma.us.novartis.com. 2018 [cited 27 March 2018]. Available from:

https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/travatan_z.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 30 Mar 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.